Erika Spens started working at SDS Life Science in 2021 as director of regulatory affairs and has more than 15 years of experience in the pharmaceutical industry, both within small and large enterprises. Her latest appointment was as director of regulatory affairs at a parent company, and Erika has experience from early development, market registration, and post-market in Europe, USA, EMENAR, Asia, and LATAM. Furthermore, she has experience with project management in development programs and responsible for large collaborations with business partners. With her doctoral degree in bioprocess technology at KTH, Sweden, Erika has deep knowledge of biological drugs. Erika's passion is to find the best road-map forward, take advantage of possibilities and risk assessment in order to make projects succeed.